Eventide is a Boston-based venture capital investor focused on life sciences and healthcare innovation. The firm backs companies with clinical data and proof of concept at the crossover stage, including therapies, medical technology, diagnostics, oncology, and AI-enabled health applications. Eventide invests primarily in the United States and has acted as a lead investor in healthcare financings, making it relevant for founders building clinically validated biotechnology, medical device, pharmaceutical, or diagnostics companies.